George K. Ng - 24 Jul 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role: Chief Executive Officer, Director
Signature: /s/ George Ng, by John J. Wolfel, as Attorney-in-Fact
Issuer symbol: PCSA
Transactions as of: 24 Jul 2025
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 18 Sep 2025, 16:21:16 UTC
Date Of Original Report: 28 Jul 2025
Previous filing: 18 Feb 2025
Next filing: 03 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ng George K	Chief Executive Officer, Director	C/O PROCESSA PHARMACEUTICALS, INC., 601 21ST STREET SUITE 300, VERO BEACH	/s/ George Ng, by John J. Wolfel, as Attorney-in-Fact	18 Sep 2025	0001638744

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PCSA	Common Stock						87,200	24 Jul 2025	George Ng IRRA FBO: George Ng
holding	PCSA	Common Stock						20,000	24 Jul 2025	Ng Cha Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	PCSA	Warrants						87,200	24 Jul 2025	Common Stock	87,200	$0.6500	George Ng IRRA FBO: George Ng
holding	PCSA	Warrants						43,600	24 Jul 2025	Common Stock	43,600	$0.6500	George Ng IRRA FBO: George Ng

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Amendment filed to retract the prior Form 4, which was filed in error.